SitemapKlarity storyJoin usMedicationServiceAbout us
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
4.9 based on 1,805 reviews
fsaAccept major insurances and cash-pay
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
4.9 based on 1,805 reviews
fsaAccept major insurances and cash-pay
Back

Anxiety

Published: May 7, 2026

Share

Telehealth Anxiety Prescribing: What PMHNPs Can Do in Pennsylvania

Share

Written by Klarity Editorial Team

Published: May 7, 2026

Telehealth Anxiety Prescribing: What PMHNPs Can Do in Pennsylvania
Table of contents
Share

You’re a psychiatrist or PMHNP wondering if you can legally prescribe anxiety medications through telehealth — and whether it makes financial sense. The short answer: yes, you can, but the specifics depend on your state, your credentials, and rapidly evolving federal rules.

Here’s what actually matters for your practice in 2026.

Federal Rules: The COVID-Era Extension You Need to Know About

The Ryan Haight Act historically required at least one in-person visit before prescribing controlled substances like benzodiazepines. That changed during COVID — and as of early 2026, those telehealth flexibilities are extended through December 2026.

This means you can:

  • Initiate benzodiazepines (alprazolam, clonazepam, lorazepam) via video visit
  • Manage Schedule IV anxiolytics entirely online
  • Prescribe stimulants for comorbid ADHD without seeing the patient in person first

Over 7 million controlled substance prescriptions were written via telemedicine in 2024 alone under these rules. The DEA and HHS extended the policy to avoid a ‘telemedicine cliff’ while they finalize permanent regulations expected later in 2026.

What this means for you: You can build a telehealth anxiety practice now, but stay alert for DEA’s final rules. The extension gives regulators time to craft a special telemedicine prescribing registration that may replace these temporary flexibilities.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-Specific Telehealth Rules: Where the Real Complexity Lives

Federal law sets the floor, but states add their own requirements — and some are far more restrictive than others.

Florida: Psychiatric Carve-Out Makes It Work

Florida generally prohibits telehealth prescribing of Schedule II controlled substances — except when treating psychiatric disorders. This explicit exemption means you can prescribe Schedule II stimulants for anxiety with comorbid ADHD via telehealth.

Benzodiazepines (Schedule IV) have no such restriction. You can prescribe them remotely as long as you:

  • Use Florida’s PDMP (E-FORCSE) before prescribing
  • Conduct an appropriate patient evaluation via video
  • Are fully licensed in Florida

Important caveat: Florida’s out-of-state telehealth provider registration does not allow controlled substance prescribing. If you’re only registered (not fully licensed), you can treat Florida patients remotely but cannot prescribe benzos or other controlled meds.

Texas: Anxiety Is Fine, Chronic Pain Is Not

Texas requires establishing a valid patient-practitioner relationship via live audio-visual exam before any prescription. The state specifically bans telemedicine treatment of chronic pain with controlled drugs — but anxiety treatment doesn’t fall under this restriction.

As a Texas-licensed psychiatrist, you can:

  • Prescribe benzodiazepines for anxiety via telehealth
  • Manage standard SSRI/SNRI therapy entirely online
  • Use Schedule IV anxiolytics if clinically appropriate

You must check the Texas PMP (Aware) before prescribing any controlled substance. Unlike some states, Texas has no telehealth-specific quantity limits for physician prescribing.

For PMHNPs in Texas: You need a prescriptive authority agreement with a physician, and you cannot prescribe Schedule II stimulants outside hospital settings. Benzodiazepines are permissible if your delegating physician authorizes it in your agreement.

California: The Independence Transition

California has no telehealth-specific restrictions on controlled substance prescribing beyond federal requirements. A California-licensed psychiatrist can manage anxiety entirely online, including prescribing Schedule IV anxiolytics or Schedule II stimulants for comorbid conditions.

For PMHNPs, California’s landscape is shifting dramatically:

  • As of January 2023, experienced NPs can become 103 NPs and practice without physician protocols in certain group settings
  • Starting 2026, those NPs can apply for 104 NP status, allowing fully independent practice including prescribing
  • Until then, new California PMHNPs operate under physician agreements

California’s AB 744 ensures private insurers pay equally for telehealth visits, removing financial disincentives to virtual care.

New York: Full Practice Authority Changes Everything

New York granted full practice authority to NPs in 2022, eliminating collaborative agreement requirements entirely. This means:

  • A New York PMHNP can open their own telehealth anxiety practice
  • No physician oversight needed for prescribing benzodiazepines
  • No written protocols required

One key requirement: New York has one of the strictest PDMP mandates. You must check the iSTOP database for every controlled substance prescription, no exceptions. This applies equally to psychiatrists and PMHNPs.

Pennsylvania & Illinois: Varying Degrees of Collaboration

Pennsylvania remains a restricted state. PMHNPs must maintain a collaborative agreement with a physician, including:

  • Chart co-signature requirements (100% for Schedule II prescriptions within 24 hours)
  • Physician review of at least 10% of charts
  • Explicit authorization in the agreement for controlled substance categories

Illinois offers a middle path: after 4,000 clinical hours and 250 CE hours, PMHNPs can apply for full practice authority. However, even FPA NPs need a one-time physician agreement acknowledging they’ll prescribe benzodiazepines and Schedule II narcotics.

PMHNP vs Psychiatrist: The Authority Gap

The practical difference in prescribing authority varies dramatically by state:

In Full Practice Authority States (NY, AZ, OR, WA, etc.):

  • PMHNPs have equivalent prescribing authority to psychiatrists
  • No supervision or collaboration required
  • Can independently manage all anxiety medications including controlled substances

In Restricted States (TX, FL, PA, etc.):

  • PMHNPs need physician agreements to prescribe
  • Some states limit Schedule II prescribing (Texas: hospital settings only for NPs)
  • Florida caps NP controlled substance prescriptions at 7 days unless the NP is a psychiatric specialist treating mental illness
  • Day-to-day practice may differ little (NPs manage SSRI therapy autonomously), but controlled anxiolytics require physician authorization

The training difference matters to some patients and payers:

  • Psychiatrists: 4 years medical school + 4 years residency
  • PMHNPs: 2-3 years graduate training (post-BSN)
  • Studies show PMHNPs provide effective medication management for routine anxiety and depression cases
  • Both work in collaborative teams regardless of legal requirements in many practices

What This Means for Your Wallet: Reimbursement Reality

Understanding reimbursement is critical when evaluating telehealth opportunities.

Medicare Rates (2026)

Medicare pays surprisingly well for psychiatric medication management:

  • Initial psychiatric evaluation (90792): ~$202
  • 15-minute follow-up (99213): ~$95
  • 25-minute follow-up (99214): ~$136
  • Therapy add-on, 30 min (90833): ~$81

Telehealth is currently paid at the same rate as in-person through at least December 2026, with likely extensions beyond that.

Medicare catch: There was a requirement for periodic in-person visits for tele-mental health, but enforcement has been delayed through 2025 and likely into 2026. Verify current policy, as this could affect pure-telehealth Medicare practices.

Medicaid: Volume Over Rate

Medicaid pays significantly less — roughly 50-60% of Medicare:

  • 90792 (initial eval): ~$85
  • 99213 (med check): ~$40-50

However, many anxiety patients are on Medicaid, and high volume can offset lower per-visit rates. Most states now permanently cover tele-mental health at parity with in-person rates.

Private Insurance

Commercial plans typically pay 100-150% of Medicare rates:

  • Med check visits: $80-$130 typically
  • Initial evals: $150-$250 in most markets

Many states have telehealth parity laws requiring equal payment for virtual visits (California, Illinois, New York among them). Texas doesn’t mandate parity by law, but many insurers voluntarily pay equivalently for tele-mental health.

The NP Rate Difference

PMHNPs billing under their own NPI receive 85% of physician rates from Medicare and many private payers. A psychiatrist getting $100 for a visit means an NP gets $85 for the same service.

Some practices use ‘incident to’ billing to get 100% rates, but this rarely works in psychiatry or telehealth due to direct provider-patient interaction requirements.

The Economics of Patient Acquisition: Why Platforms Make Sense

Here’s where most providers get the math wrong.

The DIY marketing reality:

Acquiring a psychiatric patient through your own marketing typically costs $200-500+ per booked patient when you account for:

  • SEO: 6-12 months before meaningful results, requires consistent investment
  • Google Ads: $15-40+ per click for mental health keywords, most clicks don’t convert to booked patients
  • Realistic PPC cost per booked patient: $200-400+
  • Directory listings: Monthly fees plus you compete with hundreds of other providers (Psychology Today, Zocdoc)
  • Agency/consultant fees if you don’t have expertise
  • Staff time to handle and qualify leads
  • No-show rates from cold leads
  • Failed campaigns and testing costs

The platform alternative:

Telehealth platforms like Klarity use a pay-per-appointment model similar to Zocdoc. You pay a standard listing fee per new patient lead. The value proposition:

  • No upfront marketing spend or monthly subscription fees
  • Pre-qualified patients already matched to your specialty and availability
  • No wasted ad spend on clicks that don’t convert
  • Built-in telehealth infrastructure (no separate platform costs)
  • Both insurance and cash-pay patient flow
  • You control your schedule — only pay when you see patients

Frame it this way: Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI versus gambling on marketing channels.

DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience — but for most providers, especially those starting out or scaling, a platform that handles patient acquisition removes the risk entirely.

The Provider Shortage Context: Why Demand Is Sky-High

Anxiety disorders are among the most common mental health conditions, and provider shortages make access difficult:

  • Texas: One psychiatrist per ~8,966 residents (well above the national 1:5,000 ratio)
  • Florida: Similarly high at 1:8,577
  • Illinois: Ratio of 1:5,849, with severe downstate shortages
  • Pennsylvania: Rural areas meet only 31% of mental health provider need

Post-pandemic anxiety cases surged, creating even more demand. Telehealth platforms help you reach underserved areas, and states are responding:

  • Interstate Medical Licensure Compact (IMLC) participation makes multi-state licensing easier for psychiatrists (Texas and Pennsylvania participate; California and New York don’t)
  • Some states offer telehealth-only registrations (like Florida’s out-of-state provider registration)
  • Licensure compacts for NPs exist but are separate from physician compacts

Bottom line: Joining a telepsychiatry platform gives anxiety specialists access to broader patient populations, streamlined reimbursement, and flexible practice within state regulations.

Practical Compliance: What You Actually Need to Do

To prescribe anxiety medications via telehealth legally:

For all providers:

  1. Hold active license in the state where the patient is located during the visit
  2. Conduct appropriate patient evaluation via secure video platform
  3. Check state PDMP before prescribing controlled substances
  4. Document the encounter thoroughly (note it was via telehealth, patient consent, clinical rationale)
  5. Stay current on federal DEA rules (watch for permanent regulations in late 2026)

For PMHNPs in restricted states:

  1. Maintain current collaborative agreement with physician
  2. Ensure your agreement explicitly authorizes anxiety medication prescribing
  3. Follow state-specific chart review and co-signature requirements
  4. Obtain DEA registration (some states require physician sign-off for NP DEA applications)

State-specific extras:

  • Florida: Use E-FORCSE PDMP, ensure psychiatric disorder documentation for Schedule II
  • Texas: Document patient relationship establishment, check PMP Aware
  • California: Follow AB 890 pathway if seeking NP independence
  • New York: Mandatory iSTOP check for every controlled prescription
  • Pennsylvania: Physician co-sign within 24 hours for Schedule II
  • Illinois: Apply for controlled substance license separate from DEA

FAQs: What Providers Actually Ask

Can a psychiatrist prescribe benzodiazepines via telehealth in 2026?

Yes, in all states, provided you’re licensed where the patient is located and follow federal/state controlled substance rules. The COVID-era telehealth flexibilities allowing this are extended through December 2026.

Can a PMHNP prescribe Xanax independently?

Depends on the state. In full practice authority states (NY, AZ, OR, etc.), yes. In restricted states (TX, FL, PA, etc.), you need a physician collaborative agreement that explicitly authorizes benzodiazepine prescribing.

Do I need to see anxiety patients in person first before prescribing via telehealth?

Not under current federal rules (through Dec 2026). However, verify if your state has additional requirements. Medicare may eventually require periodic in-person visits, but enforcement is delayed.

What’s the reimbursement difference between telehealth and in-person for anxiety medication management?

In states with telehealth parity laws (CA, IL, NY, and many others), there’s no difference — insurers must pay equally. Medicare currently pays equal rates for telehealth through 2026.

How much does patient acquisition cost for a private practice psychiatrist?

Realistically $200-500+ per booked patient when you factor in all marketing costs, wasted ad spend, no-shows, and time to results. Platforms charging a per-appointment fee often provide better ROI than DIY marketing, especially early in your practice growth.

Can I use a telehealth platform if I’m licensed in multiple states?

Yes, as long as you’re licensed in each state where your patients are located. IMLC participation (Texas, Pennsylvania, others) makes multi-state licensing easier for psychiatrists. NPs have separate compact options but fewer states participate.

The Bottom Line: Telehealth Anxiety Prescribing Is Viable — If You Navigate the Rules

As a psychiatrist or PMHNP, you can absolutely build a thriving telehealth practice treating anxiety patients with medication management. The federal regulatory environment is more permissive now than pre-pandemic, and most states have removed barriers to virtual psychiatric care.

The key variables:

  • Your state’s scope of practice rules (especially for NPs)
  • Federal DEA rules (current through 2026, but watch for changes)
  • Reimbursement landscape (favors telehealth with parity laws)
  • Patient acquisition economics (platforms often beat DIY for ROI)

The opportunity:

  • Massive provider shortages in key states
  • High demand for anxiety treatment post-pandemic
  • Telehealth infrastructure is proven and here to stay
  • Regulatory environment trending toward permanence

If you’re evaluating whether to join a telehealth platform like Klarity Health, the business case is clear: you get qualified patient flow without gambling thousands on marketing, you maintain schedule control, and you operate within a compliant framework that handles the state-by-state complexity.

The question isn’t whether telehealth anxiety prescribing works — it’s whether you want to figure out all the licensing, marketing, compliance, and billing yourself, or plug into a system designed for providers who want to treat patients, not run marketing campaigns.

Ready to expand your anxiety practice via telehealth? Explore how Klarity Health’s provider network handles patient acquisition, compliance, and reimbursement so you can focus on clinical care.


References

  1. U.S. Department of Health & Human Services. ‘HHS & DEA Extend Telemedicine Flexibilities Through 2026.’ HHS Press Release, January 2, 2026. www.hhs.gov

  2. Axios. ‘COVID-era telehealth prescribing extended again.’ Axios News, November 18, 2024. www.axios.com

  3. Florida State Legislature. ‘Florida Statute §456.47 – Telehealth’ and ‘§464.012 – Nurse Practice Act.’ 2024 Florida Statutes. www.flsenate.gov

  4. California Board of Registered Nursing. ‘AB 890 Implementation – Nurse Practitioner Practice Authority.’ Updated 2024. rn.ca.gov

  5. Nurse Practitioners of New York. ‘Breaking News: NP Modernization Act Passes.’ NPNY Network, April 9, 2022. npny.enpnetwork.com

Source:

Looking for support with Anxiety? Get expert care from top-rated providers

Find the right provider for your needs — select your state to find expert care near you.

Related posts

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402

Join our mailing list for exclusive healthcare updates and tips.

Stay connected to receive the latest about special offers and health tips. By subscribing, you agree to our Terms & Conditions and Privacy Policy.
logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402
If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Lifeline: call or text 988. Crisis Text Line: Text HOME to 741741.
HIPAA
© 2026 Klarity Health, Inc. All rights reserved.